ISPOR Forums
Saturday, 16 September 2017
17:30 - 18:30
BREAKOUT SESSION

17:30 - 18:30
Room: Comandatuba 3
F1: REGULATION IN HEALTH SYSTEMS AND EQUITY: LESSONS LEARNED AND FUTURE PERSPECTIVES FROM AN INEQUITABLE REGION IN THE WORLD
Presented in Portuguese and Spanish
Moderator:

Aurelio Mejia, MSc, Senior Economist, Health Technology Assessment, Instituto de Evaluación Tecnológica en Salud, Bogotá, Colombia

Speakers:

Edward M.A. Mezones-Holguín, MD, MSc, Jefe, Escuela de Postgrado, Universidad San Ignacio de Loyola, Lima, Peru

Natalia Jorgensen, MSc, Advisor, Ministry of Health, Buenos Aires, Argentina

Baltica Cabieses, PhD, Social Epidemiologist, Programa de Estudios Sociales en Salud, Instituto de Ciencias e Innovacion en Medicina, Universidad del Desarrollo, Santiago, Chile

Raquel Medeiros Lisbôa, MD, General Manager, Healthcare Regulation, Agencia Nacional de Saude Complementar, Rio de Janeiro, Brazil

DESCRIPTION:

PURPOSE: Does regulation in health systems contribute to the reduction of health inequities in the region ? An expert debate from Latin America, one of the most inequitable areas with highly fragmented health systems in the world.

DESCRIPTION: According to World Health Organization (WHO) Equity is the absence of avoidable or remediable social, economic, geographic or demographic differences among groups of people. In recent decades, Latin America has undergone progressive economic growth, however, this has also led to an accentuation of inequity both within and between countries. Latin America (LATAM) is recognized as the most unequal region in the world. To this we must add that LATAM is one of the areas where different health systems coexist, with notable differences both in terms of financing and the provision of health services, with participation from both the public and private sectors. The entire structure of health systems is based on the normativity of each country, and existing variations could generate dissimilar coverage that deepens or diminishes the differences between different population groups in terms of access to health services and the quality of health care. In that context, governments have developed regulatory bodies that seek to enforce regulatory provisions in terms of access, assurance and delivery of health services at various levels. Even in some cases, governments have opted for the generation of scientific evidence from research in health systems, and the use of the best scientific evidence to generate public policies on health regulation. This forum will provide, in the first instance, a general overview of the structure of health systems in Latin American countries, and will present experiences in terms of regulation in health systems in the region and their impact on equity. Finally, it will explore the best evidence-based strategies that contribute to optimizing the regulatory process in order to achieve a more equitable society.

Presented by the Latin America Consortia - Health Technology Assessment Council

Sunday, 17 September 2017
8:30 - 9:30
BREAKOUT SESSION

8:30 - 9:30
Room: Transamérica Auditorium
F2: DATOS Y EVIDENCIAS DEL MUNDO REAL EN LATINOAMÉRICA: ¿REALIDAD O FICCIÓN?
Presented in Spanish
Moderator:

Mariana Glancszpigel, Actuaria, Directora, 3Eff S.A., Buenos Aires, Argentina

Speakers:

Gerardo Machnicki, MSc, PhD, Director, Real World Evidence LATAM, Janssen, Buenos Aires, Argentina

Natalia Jorgensen, MSc, Advisor, Ministry of Health, Buenos Aires, Argentina

Federico Augustovski, MD, MSc, PhD, Director, Departamento de Evaluaciones Económicas y de Tecnologías Sanitarias, Instituto de Efectividad Clínica y Sanitaria (IECS), y Profesor de Salud Pública, Universidad de Buenos Aires, Buenos Aires, Argentina

Lizbeth Acuña Merchan, MSc, PhD(c), Directora Ejecutiva, Cuenta de Alto Costo, Fondo Colombiano de Enfermedades de Alto Costo, Bogotá, Colombia

DESCRIPTION:

En los últimos años, a nivel mundial las instituciones de cobertura, las organizaciones de ETS y las empresas farmacéuticas han impulsado la generación de datos y evidencias del mundo real como fuente de información que permitirá tomar decisiones mejor informadas. En Latinoamérica, los diferentes actores del sistema sanitario reconocen cada vez más la importancia de contar con información del mundo real de calidad; sin embargo, a diferencia de lo que ocurre en los países desarrollados, los datos accesibles son escasos, usualmente incompletos y fragmentados. Creando la sensación de que la toma de decisiones basada en datos o evidencias del mundo real no es posible o aplicable en los países de Latinoamérica. No obstante, hay oportunidades y diferentes puntos de vista sobre cómo mejorar la disponibilidad, acceso y uso de datos del mundo real en los países latinoamericanos. En este sentido, este foro a través de una serie de presentaciones de expertos abordará el estado actual del tema en la región, los desafíos/barreras, oportunidades y ejemplos recientes de implementación. Generando debate sobre la situación actual real y los aspectos claves hacia donde direccionar los esfuerzos para incrementar las capacidades de generación de datos y evidencias de calidad en Latinoamérica.
Presented by ISPOR Argentina Chapter

16:00 - 17:00
BREAKOUT SESSION

16:00 - 17:00
Room: Comandatuba 2
F3: ADAPTIVE PATHWAYS AND PATIENT ACCESS – IS THERE A PLACE FOR NEW PAYMENT MODELS?
Presented in English and Spanish with simultaneous English/Portuguese/Spanish interpretation
Moderator:

Marcelo Fonseca, MD, MSc, PhD, Professor, Federal University of São Paulo, São Paulo, Brazil

Speakers:

Rosa Maria Galindo Suarez, MHA, Deputy General Director of Prioritization, General Health Council, Mexico City, Mexico

Alarico Rodríguez, MD, Director Técnico Médico, Fondo Nacional de Recursos para la Medicina Altamente Especializada, Montevideo, Uruguay

Diego F Guarin, MD, MPH, MA, Senior Director, HEOR & HTA Strategy, HEOR & HTA, Latin America, Merck-Serono, Billerica, MA, USA

Finn Børlum Kristensen, MD, PhD, Professor, Faculty of Health Sciences, University of Southern Denmark, Hilleroed, Denmark bio

DESCRIPTION:

Adaptive Pathways to Patients (APPS) seeks to foster access to beneficial treatments for the right patient groups at the earliest appropriate time in a sustainable fashion. From an access perspective, implies that stakeholders (regulators, HTA agencies and payers, manufacturers, patient groups, clinicians, etc.) find implementable solutions for decision on pricing and coverage while dealing with remaining uncertainties regarding the product therapeutic and economic value, warranting additional evidence generation in real life. Solutions may include more flexible approaches to pricing and reimbursement than those currently used. Will there be more use of outcome-based agreements?. In this session, learnings from payers, HTA, regulators and industry’s concerns on APPS and managed entry agreements along with their perspectives on the challenges and enablers on applicability to possible adaptive scenarios. Rosa Maria Galindo will share the regulatory perspective, Alarico Rodriguez will provide the High Cost found perspective and Diego Guarin Garcia will represent the industry perspective
Presented by ISPOR Latin America Consortium

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.